CeriBell, Inc. (CBLL) Stock Ticker
CBLL right now
Market factors today
Unlock the full CBLL picture
About CeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
CBLL stock facts
| Ticker symbol | CBLL |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $898.9M |
| CEO | Xingjuan Chao |
| Employees | 327 |
| Headquarters | Sunnyvale, CA, US |
| IPO date | 2024-10-11 |
| Website | ceribell.com |
What you can see for CBLL on Tickr
Live CBLL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CBLL report.
Rankings
FAQ
What is the ticker symbol for CeriBell, Inc.?
The ticker symbol for CeriBell, Inc. is CBLL, listed on the NASDAQ Global Select.
What is CBLL?
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in…